株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

CRISPR技術の世界市場の分析・予測 (2018-2027年):製品・用途・地域別

Global CRISPR Technology Market: Focus on Product, Applications, Geographical Analysis, Industry Insights and Competitive Landscape - Analysis and Forecast 2018-2027

発行 BIS Research Inc. 商品コード 628079
出版日 ページ情報 英文 335 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=111.19円で換算しております。
Back to Top
CRISPR技術の世界市場の分析・予測 (2018-2027年):製品・用途・地域別 Global CRISPR Technology Market: Focus on Product, Applications, Geographical Analysis, Industry Insights and Competitive Landscape - Analysis and Forecast 2018-2027
出版日: 2018年04月20日 ページ情報: 英文 335 Pages
概要

世界のCRISPR技術の市場は2017年には105億5000万ドルの規模に成長すると予測されています。

当レポートでは、世界のCRISPR技術の市場を調査し、市場および技術の定義と概要、市場成長への各種影響因子および市場機会の分析、競合環境と企業および企業間の各種動向、製品・用途・地域/主要国別の動向と市場規模の推移と予測、主要企業のプロファイルなどをまとめています。

Figure Global CRSIPR Technology Market(2017 -2027)

エグゼクティブサマリー

第1章 市場概要

  • イントロダクション
  • CRISPR技術アプローチ
  • CRISPR技術の進歩
  • CRISPR技術:関心領域
  • CRISPR技術:将来の潜在性
  • 世界市場
  • 前提因子・制約

第2章 市場力学

  • 概要
  • 影響分析
  • 成長推進因子
  • 成長抑制因子
  • 市場機会

第3章 競合環境

  • イントロダクション
  • 主な展開・戦略
  • 製品の投入・強化
  • JV・提携・協力
  • M&A
  • 事業拡張・契約獲得・認証など
  • 産業の魅力
  • パイプライン分析

第4章 産業分析

  • イントロダクション
  • 特許分析
  • 資金調達シナリオ
    • 公的企業
    • 民間企業
    • 政府機関による投資
  • 法的要件・法規制
  • 規制団体のリスト

第5章 世界のCRISPR技術市場の分析・予測:製品別

  • 概要
  • 設計ツール
  • ライブラリ
  • コントロールキット
  • プラスミド
  • ベクター
  • タンパク質
    • Cas9
    • Cpf1
    • その他
  • gRNA
  • その他

第6章 世界のCRISPR技術市場の分析・予測:用途別

  • 概要
  • 生物学研究
  • 農業バイオテクノロジー
  • 工業バイオテクノロジー
  • 治療・創薬

第7章 地域分析・予測

  • 概要
  • 世界的考察
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • スぺイン
    • イタリア
    • スイス
    • その他
  • アジア太平洋
    • 日本
    • 中国
    • 韓国
    • シンガポール
    • インド
    • その他
  • その他の地域

第8章 企業プロファイル

  • Agilent Technologies, Inc.
  • Applied StemCell, Inc.
  • Cellecta, Inc.
  • Dharmacon, Inc.
  • DiaCarta, Inc.
  • EdiGene, Inc.
  • GeneCopoeia, Inc.
  • Genedata AG
  • GeneScript
  • Integrated DNA Technologies (IDT), Inc.
  • Mirus Bio LLC
  • New England Biolabs
  • OriGene Technologies, Inc.
  • Oxford Genetics Ltd.
  • Rockland Immunochemicals, Inc.
  • Sigma Aldrich Corporation
  • Synthego Corporation
  • System Biosciences, LLC
  • Takara Bio USA Inc.
  • Thermo Fisher Scientific Inc.
  • transOMIC technologies inc.
  • Transposagen Biopharmaceuticals

第9章 調査範囲・調査手法

付録1:近年の主な展開・特許環境

付録2:製品マッピング・価格分析

図表

List of Tables

  • 1. Global CRISPR Technology Market (2017 & 2027)
  • 2. Impact Analysis of Market Dynamics
  • 3. Pipeline Analysis of Biopharmaceutical Companies using CRISPR Technology
  • 4. Funding Scenario of Public Companies
  • 5. Funding Scenario of Private Companies
  • 6. Funding Scenario of Government Organizations
  • 7. List of Regulatory Bodies
  • 8. Europe CRISPR Technology Market, by Country, $Million (2017-2027)
  • 9. Asia Pacific CRISPR Technology Market, by Country, $Million (2017-2027)
  • 10. Agilent Technologies, Inc.: Product Developments
  • 11. Applied StemCell, Inc.: Other Developments
  • 12. Applied StemCell, Inc.: Merger And Acquisition
  • 13. Horizon Discovery plc: Product Developments
  • 14. Horizon Discovery plc: Merger, Acquisition & Collaboration
  • 15. EdiGene, Inc.: Agreements and Other Developments
  • 16. Genedata AG: Agreements and Collaboration
  • 17. Genedata AG: Product Developments
  • 18. Genedata AG: Other Developments
  • 19. GenScript: Product Developments
  • 20. Integrated DNA Technologies, Inc.: Product Developments
  • 21. Integrated DNA Technologies, Inc.: Merger and Acquisition
  • 22. Mirus Bio LLC: Product Developments
  • 23. OriGene Technologies, Inc.: Product Developments
  • 24. Oxford Genetics Ltd.: Agreements and Other Developments
  • 25. Merck KGaA: Partnerships, Collaboration, Acquisition and Joint Venture
  • 26. Merck KGaA: Other Developments
  • 27. Synthego Corporation: Product Developments
  • 28. Synthego Corporation : Other Developments
  • 29. Takara Bio USA Inc.: Product Developments
  • 30. Takara Bio USA Inc.: Merger and Acquisition
  • 31. Thermo Fisher Scientific Inc.: Product Developments
  • 32. Thermo Fisher Scientific Inc.: Merger and Acquisition
  • 33. transOMIC technologies inc.: Product Developments

List of Figures

  • 1. Impact of Market Drivers and Market Restraints
  • 2. Market Statistics
  • 3. Global CRISPR Technology Market, by Product ($Million)
  • 4. Global CRISPR Technology Market, by Product, 2017
  • 5. Global CRISPR Technology Market, by Product, 2027
  • 6. Global CRISPR Technology Market, by Application, 2017
  • 7. Global CRISPR Technology Market, by Application, 2027
  • 8. Global CRISPR Technology Market Value, by Region, 2017 & 2027 ($Million)
  • 9. Global CRISPR Technology Market, by Region, 2017
  • 10. Global CRISPR Technology Market, by Region, 2027
  • 11. Advantages of CRISPR Technology
  • 12. CRISPR Technology Approach
  • 13. Evolution of CRISPR Technology
  • 14. CRISPR Technology: Areas of Interest
  • 15. Future Potential of CRISPR Technology
  • 16. Global CRSIPR Technology Market (2017-2027)
  • 17. Market Dynamics
  • 18. Competitive Landscape (January 2014-February 2018)
  • 19. Share of Key Developments and Strategies (January 2014-February 2018)
  • 20. Product Launch Share, by Companies
  • 21. Joint Ventures, Partnerships, and Collaborations Share, by Companies
  • 22. Porter's Five Forces Analysis
  • 23. Industry Insights (January 2014-February 2018)
  • 24. Funding Scenario Share, by Type of Companies/Organization
  • 25. CRISPR Technology Market, by Product
  • 26. Global CRISPR Technology Market, by Product (2017-2027)
  • 27. Different Designing Tools
  • 28. Global CRISPR Technology Market, by Designing Tools (2017-2027)
  • 29. Types of Library
  • 30. Global CRISPR Technology Market, by Library (2017-2027)
  • 31. Types of Controls
  • 32. Global CRISPR Technology Market, by Control Kits (2017-2027)
  • 33. Types of Plasmids
  • 34. Global CRISPR Technology Market, by Plasmids (2017-2027)
  • 35. Types of Vectors
  • 36. Global CRISPR Technology Market, by Vectors (2017-2027)
  • 37. Types of Proteins
  • 38. Global CRISPR Technology Market, by Proteins (2017-2027)
  • 39. Global CRISPR Technology Market, by Cas9 (2017-2027)
  • 40. Global CRISPR Technology Market, by Cpf1 (2017-2027)
  • 41. Global CRISPR Technology Market, by Others (2017-2027)
  • 42. Global CRISPR Technology Market, by gRNA (2017-2027)
  • 43. Global CRISPR Technology Market, by Others (2017-2027)
  • 44. Global CRISPR Technology Market Share, by Application, 2017
  • 45. Global CRISPR Technology Market Share, by Application, 2017
  • 46. Global CRISPR Technology Market, by Application (2017-2027)
  • 47. Application of CRISPR Technology in Biological Research
  • 48. Global CRISPR Technology Market, by Biological Research (2017-2027)
  • 49. Application of CRISPR Technology in Agricultural Research
  • 50. Global CRISPR Technology Market, by Agricultural Biotech (2017-2027)
  • 51. Global CRISPR Technology Market, by Industrial Biotech (2017-2027)
  • 52. Global CRISPR Technology Market, by Therapeutics and Drug Discovery (2017-2027)
  • 53. Global CRSIPR Technology Market, by Region (2017-2027)
  • 54. Global CRISPR Technology Market Share, by Region (2017)
  • 55. Global CRISPR Technology Market Share, by Region (2027)
  • 56. North America CRISPR Technology Market (2017-2027)
  • 57. North America CRISPR Technology Market, by Country (2017-2027)
  • 58. The U.S. CRISPR Technology Market (2017-2027)
  • 59. Canada CRISPR Technology Market (2017-2027)
  • 60. Europe CRISPR Technology Market (2017-2027)
  • 61. The U.K. CRISPR Technology Market (2017-2027)
  • 62. Germany CRISPR Technology Market (2017-2027)
  • 63. France CRISPR Technology Market (2017-2027)
  • 64. Spain CRISPR Technology Market (2017-2027)
  • 65. Italy CRISPR Technology Market (2017-2027)
  • 66. Switzerland CRISPR Technology Market (2017-2027)
  • 67. Rest of the Europe CRISPR Technology Market (2017-2027)
  • 68. Asia Pacific CRISPR Technology Market (2017-2027)
  • 69. Japan CRISPR Technology Market (2017-2027)
  • 70. China CRISPR Technology Market (2017-2027)
  • 71. South Korea CRISPR Technology Market (2017-2027)
  • 72. Singapore CRISPR Technology Market (2017-2027)
  • 73. India CRISPR Technology Market (2017-2027)
  • 74. Rest of Asia Pacific CRISPR Technology Market (2017-2027)
  • 75. Rest of the World CRISPR Technology Market (2017-2027)
  • 76. Agilent Technologies, Inc.: Overall Product Portfolio
  • 77. Agilent Technologies, Inc.: Product Portfolio for Global CRISPR Technology
  • 78. Agilent Technologies, Inc.: Overall Financials (2014-2017)
  • 79. Agilent Technologies, Inc.: Revenue by Business Segment (2014-2017)
  • 80. Agilent Technologies, Inc.: Revenue by Region (2014-2017)
  • 81. Agilent Technologies, Inc.: Global Presence
  • 82. Agilent Technologies, Inc.: SWOT Analysis
  • 83. Applied StemCell, Inc.: Overall Product Portfolio
  • 84. Applied StemCell, Inc.: Product Portfolio for Global CRISPR Technology
  • 85. Applied StemCell, Inc.: SWOT Analysis
  • 86. Cellecta, Inc.: Overall Product Portfolio
  • 87. Cellecta, Inc.: Product Portfolio for Global CRISPR Technology
  • 88. Cellecta, Inc.: SWOT Analysis
  • 89. Horizon Discovery plc: Overall Product Portfolio
  • 90. Horizon Discovery plc (Dharmacon, Inc.): Product Portfolio for Global CRISPR Technology
  • 91. Horizon Discovery plc: Overall Financials (2014-2016)
  • 92. Horizon Discovery plc: Net Revenue by Business Segment (2014-2016)
  • 93. Horizon Discovery plc: Net Revenue by Region (2014-2016)
  • 94. Horizon Discovery plc: Global Presence
  • 95. Horizon Discovery plc: SWOT Analysis
  • 96. EdiGene, Inc.: Overall Product Portfolio
  • 97. EdiGene, Inc.: Product Portfolio for Global CRISPR Technology
  • 98. EdiGene, Inc.: SWOT Analysis
  • 99. GeneCopoeia, Inc.: Overall Product Portfolio
  • 100. GeneCopoeia, Inc.: Product Portfolio for Global CRISPR Technology
  • 101. GeneCopoeia, Inc.: SWOT Analysis
  • 102. Genedata AG: Overall Product Portfolio
  • 103. Genedata AG: Product Portfolio for Global CRISPR Technology
  • 104. Genedata AG: SWOT Analysis
  • 105. GenScript: Overall Product Portfolio
  • 106. GenScript: Product Portfolio for Global CRISPR Technology
  • 107. GenScript: Overall Financials (2014-2016)
  • 108. GenScript: Net Revenue by Business Segment (2014-2016)
  • 109. GenScript: Net Revenue by Region (2014-2016)
  • 110. GenScript: Global Presence
  • 111. GenScript: SWOT Analysis
  • 112. Integrated DNA Technologies, Inc.: Overall Product Portfolio
  • 113. Integrated DNA Technologies, Inc.: Product Portfolio for Global CRISPR Technology
  • 114. Integrated DNA Technologies, Inc.: SWOT Analysis
  • 115. Mirus Bio LLC : Overall Product Portfolio
  • 116. Mirus Bio LLC: Product Portfolio for Global CRISPR Technology
  • 117. Mirus Bio LLC: SWOT Analysis
  • 118. New England Biolabs: Overall Product Portfolio
  • 119. New England Biolabs: Product Portfolio for Global CRISPR Technology
  • 120. New England Biolabs: SWOT Analysis
  • 121. OriGene Technologies, Inc.: Overall Product Portfolio
  • 122. OriGene Technologies, Inc.: Product Portfolio for Global CRISPR Technology
  • 123. OriGene Technologies, Inc.: SWOT Analysis
  • 124. Oxford Genetics Ltd.: Overall Product Portfolio
  • 125. Oxford Genetics Ltd. : Product Portfolio for Global CRISPR Technology
  • 126. Oxford Genetics Ltd.: SWOT Analysis
  • 127. Rockland Immunochemicals, Inc: Overall Product Portfolio
  • 128. Rockland Immunochemicals, Inc: Product Portfolio for Global CRISPR Technology
  • 129. Rockland Immunochemicals, Inc: SWOT Analysis
  • 130. Merck KGaA: Overall Product Portfolio
  • 131. Merck KGaA (Sigma Aldrich Corporation): Product Portfolio for Global CRISPR Technology
  • 132. Merck KGaA: Overall Financials, (2014-2016)
  • 133. Merck KGaA: Net Revenue by Business Segments, (2014-2016)
  • 134. Merck KGaA: Net Revenue by Geography, (2014)
  • 135. Merck KGaA: Net Revenue by Geography, (2015-2016)
  • 136. Merck KGaA: Global Presence
  • 137. Merck KGaA: SWOT Analysis
  • 138. Synthego Corporation: Overall Product Portfolio
  • 139. Synthego Corporation: Product Portfolio for Global CRISPR Technology
  • 140. Synthego Corporation: SWOT Analysis
  • 141. System Biosciences, LLC: Overall Product Portfolio
  • 142. System Biosciences, LLC: Product Portfolio for Global CRISPR Technology
  • 143. System Biosciences, LLC: SWOT Analysis
  • 144. Takara Bio Inc. : Overall Product Portfolio
  • 145. Takara Bio Inc. (Takara Bio USA Inc.): Product Portfolio for Global CRISPR Technology
  • 146. Takar Bio Inc.: Overall Financials (2014-2017)
  • 147. Takara Bio Inc.: Net Revenue by Business Segment (2014-2017)
  • 148. Takara Bio Inc.: Net Revenue by Region (2014-2017)
  • 149. Takara Bio Inc.: Global Presence
  • 150. Takara Bio Inc.: SWOT Analysis
  • 151. Thermo Fisher Scientific Inc.: Overall Product Portfolio
  • 152. Thermo Fisher Scientific Inc.: Product Portfolio for Global CRISPR Technology
  • 153. Thermo Fisher Scientific Inc.: Overall Financials (2014-2017)
  • 154. Thermo Fisher Scientific Inc.: Net Revenue by Business Segment (2014-2017)
  • 155. Thermo Fisher Scientific Inc.: Net Revenue by Region (2014-2016)
  • 156. Thermo Fisher Scientific Inc.: Global Presence
  • 157. Thermo Fisher Scientific Inc.- SWOT Analysis
  • 158. transOMIC technologies inc.: Overall Product Portfolio
  • 159. transOMIC technologies inc.: Product Portfolio for Global CRISPR Technology
  • 160. transOMIC technologies inc.: SWOT Analysis
  • 161. Transposagen Biopharmaceuticals: Overall Product Portfolio
  • 162. Transposagen Biopharmaceuticals: Product Portfolio for Global CRISPR Technology
  • 163. Transposagen Biopharmaceuticals: SWOT Analysis
  • 164. Global CRISPR Technology Market Segmentation
  • 165. Considered Factors for Data Prediction & Modeling
目次
Product Code: BH051A

Genetic diseases have been responsible for approximately 25% of the global economic burden for diseases. The advent of CRISPR technology has transformed the field of genome editing and paved pathways for development of several gene therapies for the treatment of various genetic diseases. The global CRISPR technology market is expected to reach $10.55 billion by 2027.

The CRISPR technology industry is focused on the development of gene therapeutics for the treatment of various genetic disorders such as thalassemia, haemophilia, and sickle cell anaemia, among others. The increasing prevalence of genetic disorders is promoting the growth of the CRISPR technology, for better treatment and improved quality of life of patients.

The CRISPR technology include designing tools, library, control kits, plasmids, vectors, proteins, gRNA and other products to perform the desired experiment and study the obtained results. Currently, CRISPR technology is considered a valuable tool for the biotechnology and biopharmaceutical companies to conduct cost effective and highly efficient genome editing procedures. Moreover, advancements of CRISPR technology reduced turn-around time and complexity of genome editing process. The CRISPR technology provides several opportunities to develop the one-time treatment for various rare genetic disorders. The pharmaceutical industry is witnessing the growth of pipeline of candidates developed using CRISPR technology. Several biopharmaceutical companies are now indulging in the research and development of such CRISPR based therapies. Furthermore, the advent of genome editing technologies in molecular research has enabled the companies to target the root cause of genetic and chronic diseases, with one-time procedure and develop gene therapeutics to remain competitive in the market.

The purpose of this study is to gain a holistic view of the CRISPR technology market in terms of various influencing factors, such as recent trends, regulatory requirements, and technological advancements of the market. The scope of this report constitutes a detailed study of the products associated with the global CRISPR technology market, across different regions. The market has been segmented into ‘product', ‘application', and ‘regions'. The report presents the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well-informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering into the market.

This research report aims at answering various aspects of the global CRISPR technology market with the help of the key factors driving the market, restraints and challenges that can possibly inhibit the overall market growth, and the current growth opportunities that are going to shape the future trajectory of the market expansion. The report includes an in-depth examination of the key players and recent developments taking place in this market. Moreover, the report includes chapters on market dynamics (market drivers, opportunities and challenges) and industry analysis as well.

The research study highlights the factors governing the industry attractiveness with Porter's Five Forces for a comprehensive understanding of the global CRISPR technology market. Moreover, the study includes detailed product mapping with further sub-segmentation in various countries, and in each sub-segment the key market trends, list of the key companies, and the key strategies and developments, have been discussed.

The answers to the following key questions can be derived from this report:

  • How did the CRISPR technology market evolve, and what is its scope in the future?
  • What are the major market drivers, challenges and opportunities in the global CRISPR technology market?
  • What are the key developmental strategies that are being implemented by the key players to sustain in this market?
  • How are the influencing factors will affect the industry attractiveness?
  • How the CRISPR technology is being utilized for the development of therapeutics?
  • How the investments by public & private companies, and government organizations will affect the global CRISPR technology market?
  • What was the market size of the leading segments and sub-segments of the global CRISPR technology market in 2017?
  • How will the industry evolve during the forecast period 2018- 2027?
  • What will be the growth rate of the CRISPR technology during the forecast period?
  • How will each segment of the global CRISPR technology market grow during the forecast period and what will be the revenue generated by each of the segments by the end of 2027?
  • Which product segment, and application segment is expected to register the highest CAGR for the CRISPR technology market?
  • What are the major benefits of the implementation of CRISPR technology in different field of applications including biological research, agricultural biotech, industrial biotech, and therapeutics & drug discovery?
  • What is the market size of CRISPR technology in different countries of the world?
  • Which geographical region will contribute to the highest sales of CRISPR technology?
  • Who are the key players in the CRISPR technology market and what are their contributions?

The key players who have been contributing significantly to the CRISPR technology market include Agilent Technologies, Inc., Applied StemCell, Inc., Cellecta, Inc., Horizon Discovery plc, EdiGene, Inc., GeneCopoeia, Inc., Genedata AG, GeneScript, Integrated DNA Technologies (IDT), Inc., Mirus Bio LLC, New England Biolabs, OriGene Technologies, Inc., Oxford Genetics Ltd., Rockland Immunochemicals, Inc., Merck KGaA, Synthego Corporation, System Biosciences, LLC, Takara Bio Inc., Thermo Fisher Scientific, transOMIC technologies inc., and Transposagen Biopharmaceuticals, among others.

Table of Contents

Executive Summary

1. Market Overview

  • 1.1. Introduction
  • 1.2. CRISPR Technology Approach
  • 1.3. Evolution of CRISPR Technology
  • 1.4. CRISPR Technology: Areas of Interest
  • 1.5. CRISPR Technology: Future Potential
  • 1.6. Global Market
  • 1.7. Assumptions and Limitations

2. Market Dynamics

  • 2.1. Overview
  • 2.2. Impact Analysis
  • 2.3. Market Drivers
  • 2.4. Market Restraints
  • 2.5. Market Opportunities

3. Competitive Landscape

  • 3.1. Introduction
  • 3.2. Key Developments and Strategies
  • 3.3. Product Launches and Enhancements
  • 3.4. Joint Ventures, Partnerships and Collaborations
  • 3.5. Mergers and Acquisitions
  • 3.6. Business Expansions, Awards, Recognitions, Certifications and Others
  • 3.7. Industry Attractiveness
    • 3.7.1. Bargaining Power of Suppliers
    • 3.7.2. Bargaining Power of Buyers
    • 3.7.3. Threat of New Entrants
    • 3.7.4. Threat of Substitute Products
    • 3.7.5. Intensity of Competitive Rivalry
  • 3.8. Pipeline Analysis

4. Industry Insights

  • 4.1. Introduction
  • 4.2. Patent Analysis
  • 4.3. Funding Scenario
    • 4.3.1. Funding Scenario: Public Companies
    • 4.3.2. Funding Scenario: Private Companies
    • 4.3.3. Funding Scenario: Investments by Government Organizations
  • 4.4. Legal Requirements and Regulations
  • 4.5. List of Regulatory Bodies

5. Global CRISPR Technology Market, by Product

  • 5.1. Overview
  • 5.2. Designing Tools
  • 5.3. Library
  • 5.4. Control Kits
  • 5.5. Plasmids
  • 5.6. Vectors
  • 5.7. Proteins
    • 5.7.1. Cas9
    • 5.7.2. Cpf1
    • 5.7.3. Others
  • 5.8. Grna
  • 5.9. Others

6. Global CRISPR Technology Market, by Application

  • 6.1. Overview
  • 6.2. Biological Research
  • 6.3. Agricultural Biotech
  • 6.4. Industrial Biotech
  • 6.5. Therapeutics and Drug Discovery

7. Global CRISPR Technology Market, by Region

  • 7.1. Overview
  • 7.2. Global Insights
  • 7.3. North America
    • 7.3.1. North America Market Dynamics
    • 7.3.2. North America Market, by Country
      • 7.3.2.1. The U.S.
      • 7.3.2.2. Canada
  • 7.4. Europe
    • 7.4.1. Europe Market Dynamics
    • 7.4.2. Europe Market, by Country
      • 7.4.2.1. The U.K.
      • 7.4.2.2. Germany
      • 7.4.2.3. France
      • 7.4.2.4. Spain
      • 7.4.2.5. Italy
      • 7.4.2.6. Switzerland
      • 7.4.2.7. Rest of the Europe
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific Market Dynamics
    • 7.5.2. Asia Pacific, by Country
      • 7.5.2.1. Japan
      • 7.5.2.2. China
      • 7.5.2.3. South Korea
      • 7.5.2.4. Singapore
      • 7.5.2.5. India
      • 7.5.2.6. Rest of Asia Pacific
  • 7.6. Rest of the World

8. Company Profiles

  • 8.1. Agilent Technologies, Inc.
    • 8.1.1. Overview
    • 8.1.2. Overall Product Portfolio
    • 8.1.3. Product Offerings for Global CRISPR Technology Market
    • 8.1.4. Financials
  • 8.1.4.1. Financial Summary
  • 8.1.5. Global Presence
    • 8.1.6. Recent Developments
    • 8.1.7. SWOT Analysis
  • 8.2. Applied StemCell, Inc.
    • 8.2.1. Overview
    • 8.2.2. Corporate Summary
    • 8.2.3. Product Offerings for Global CRISPR Technology Market
    • 8.2.4. Recent Developments
    • 8.2.5. SWOT Analysis
  • 8.3. Cellecta, Inc.
    • 8.3.1. Overview
    • 8.3.2. Corporate Summary
    • 8.3.3. Product Offerings for Global CRISPR Technology Market
    • 8.3.4. SWOT Analysis
  • 8.4. Dharmacon, Inc.
    • 8.4.1. Overview
    • 8.4.2. Overall Product Portfolio
    • 8.4.3. Product Offerings for Global CRISPR Technology Market
    • 8.4.4. Financials
      • 8.4.4.1. Financial Summary
    • 8.4.5. Global Presence
    • 8.4.6. Recent Developments
    • 8.4.7. SWOT Analysis
  • 8.5. DiaCarta, Inc.
    • 8.5.1. Overview
    • 8.5.2. Corporate Summary
    • 8.5.3. Product Offerings for Global CRISPR Technology Market
    • 8.5.4. Global Presence
    • 8.5.5. Recent Developments
    • 8.5.6. SWOT Analysis
  • 8.6. EdiGene, Inc.
    • 8.6.1. Overview
    • 8.6.2. Corporate Summary
    • 8.6.3. Product Offerings for Global CRISPR Technology Market
    • 8.6.4. Recent Developments
    • 8.6.5. SWOT Analysis
  • 8.7. GeneCopoeia, Inc.
    • 8.7.1. Overview
    • 8.7.2. Corporate Summary
    • 8.7.3. Product Offerings for Global CRISPR Technology Market
    • 8.7.4. SWOT Analysis
  • 8.8. Genedata AG
    • 8.8.1. Overview
    • 8.8.2. Corporate Summary
    • 8.8.3. Product Offerings for Global CRISPR Technology Market
    • 8.8.4. Recent Developments
    • 8.8.5. SWOT Analysis
  • 8.9. GeneScript
    • 8.9.1. Overview
    • 8.9.2. Overall Product Portfolio
    • 8.9.3. Product Offerings for Global CRISPR Technology Market
    • 8.9.4. Financials
      • 8.9.4.1. Financial Summary
    • 8.9.5. Global Presence
    • 8.9.6. Recent Developments
    • 8.9.7. SWOT Analysis
  • 8.10. Integrated DNA Technologies (IDT), Inc.
    • 8.10.1. Overview
    • 8.10.2. Corporate Summary
    • 8.10.3. Product Offerings for Global CRISPR Technology Market
    • 8.10.4. Recent Developments
    • 8.10.5. SWOT Analysis
  • 8.11. Mirus Bio LLC
    • 8.11.1. Overview
    • 8.11.2. Corporate Summary
    • 8.11.3. Product Offerings for Global CRISPR Technology Market
    • 8.11.4. Recent Developments
    • 8.11.5. SWOT Analysis
  • 8.12. New England Biolabs
    • 8.12.1. Overview
    • 8.12.2. Corporate Summary
    • 8.12.3. Product Offerings for Global CRISPR Technology Market
    • 8.12.4. SWOT Analysis
  • 8.13. OriGene Technologies, Inc.
    • 8.13.1. Overview
    • 8.13.2. Corporate Summary
    • 8.13.3. Product Offerings for Global CRISPR Technology Market
    • 8.13.4. Recent Developments
    • 8.13.5. SWOT Analysis
  • 8.14. Oxford Genetics Ltd.
    • 8.14.1. Overview
    • 8.14.2. Corporate Summary
    • 8.14.3. Product Offerings for Global CRISPR Technology Market
    • 8.14.4. Recent Developments
    • 8.14.5. SWOT Analysis
  • 8.15. Rockland Immunochemicals, Inc.
    • 8.15.1. Overview
    • 8.15.2. Corporate Summary
    • 8.15.3. Product Offerings for Global CRISPR Technology Market
    • 8.15.4. SWOT Analysis
  • 8.16. Sigma Aldrich Corporation (A Subsidiary of Merck KGaA)
    • 8.16.1. Overview
    • 8.16.2. Overall Product Portfolio
    • 8.16.3. Product Offerings for Global CRISPR Technology Market
    • 8.16.4. Financials
      • 8.16.4.1. Financial Summary
    • 8.16.5. Global Presence
    • 8.16.6. Recent Developments
    • 8.16.7. SWOT Analysis
  • 8.17. Synthego Corporation
    • 8.17.1. Overview
    • 8.17.2. Corporate Summary
    • 8.17.3. Product Offerings for Global CRISPR Technology Market
    • 8.17.4. Recent Developments
    • 8.17.5. SWOT Analysis
  • 8.18. System Biosciences, LLC
    • 8.18.1. Overview
    • 8.18.2. Corporate Summary
    • 8.18.3. Product Offerings for Global CRISPR Technology Market
    • 8.18.4. SWOT Analysis
  • 8.19. Takara Bio USA Inc. (A Subsidiary of Takara Bio Inc.)
    • 8.19.1. Overview
    • 8.19.2. Overall Product Portfolio
    • 8.19.3. Product Offerings for Global CRISPR Technology Market
    • 8.19.4. Financials
      • 8.19.4.1. Financial Summary
    • 8.19.5. Global Presence
    • 8.19.6. Recent Developments
    • 8.19.7. SWOT Analysis
  • 8.20. Thermo Fisher Scientific Inc.
    • 8.20.1. Overview
    • 8.20.2. Overall Product Portfolio
    • 8.20.3. Product Offerings for Global CRISPR Technology Market
    • 8.20.4. Financials
      • 8.20.4.1. Financial Summary
    • 8.20.5. Global Presence
    • 8.20.6. Recent Developments
    • 8.20.7. SWOT Analysis
  • 8.21. transOMIC technologies inc.
    • 8.21.1. Overview
    • 8.21.2. Corporate Summary
    • 8.21.3. Product Offerings for Global CRISPR Technology Market
    • 8.21.4. Recent Developments
    • 8.21.5. SWOT Analysis
  • 8.22. Transposagen Biopharmaceuticals
    • 8.22.1. Overview
    • 8.22.2. Corporate Summary
    • 8.22.3. Product Offerings for Global CRISPR Technology Market
    • 8.22.4. SWOT Analysis

9. Report Scope & Methodology

  • 9.1. Scope of the Report
  • 9.2. Global CRISPR Technology Market Segmentation
  • 9.3. Research Methodology
    • 9.3.1. Primary Research
    • 9.3.2. Secondary Research
    • 9.3.3. Key Data Points from Primary Sources
    • 9.3.4. Key Data Points from Secondary Sources
    • 9.3.5. Data Triangulation
    • 9.3.6. Top-Down Approach (Segment wise Analysis)
    • 9.3.7. Bottom-Up Approach (Segmental Analysis)
  • 9.4. Assumptions and Limitations
  • 9.5. Data and Prediction Modelling

I. Annexure 1: Recent Key Developments (2014 - 2018) and Patent Landscape

II. Annexure 2: Product Mapping and Pricing Analysis

Back to Top